- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on XLA
Total 73 results
-
University of CincinnatiMillennium Pharmaceuticals, Inc.Completed
-
National Institute of Allergy and Infectious Diseases...RecruitingCVID | XLAUnited States
-
Life Technologies CorporationCompletedHuman Leukocyte Antigens (HLA)
-
University Hospital, BrestCompletedNext Generation Sequencing for HLA TypingFrance
-
Catholic University of the Sacred HeartCompletedCLA Intake From Different Food Sources
-
Anhui Provincial HospitalNot yet recruitingHigh Titers of Anti-HLA Antibody (MFI ≥5000)China
-
DatabeanOctapharmaTerminatedRenal Transplant Recipients With Anti-HLA AntibodiesUnited States
-
Central Hospital, Nancy, FranceActive, not recruitingKidney Transplantation | Dialysis | Immunosuppressive Agents | HLA SensitizationFrance
-
Northwestern UniversityTerminatedTransplant Sensitization | Panel Reactive Antibody | Sensitization to HLA AntigensUnited States
-
Hannover Medical SchoolRecruitingLung Transplantation | Donor-specific Anti-human Leukocyte Antigen(HLA) AntibodiesGermany
-
Assistance Publique - Hôpitaux de ParisEtablissement Français du Sang (Nouvelle Aquitaine)Recruiting
-
Inonu UniversityCompletedLiver Transplant; Complications | HLA AntigensTurkey
-
Corporacion Parc TauliCompletedCeliac Disease Patients Following Recommendations of ESPGHAN | HLA-DQ2 Typing Include HLA-DR7-DQ2 HaplotypesSpain
-
Assistance Publique - Hôpitaux de ParisCompletedPatients With Advanced Lymphoid Malignancies in the Absence of an HLA Identical or Mismatch DonorFrance
-
National Institute of Allergy and Infectious Diseases...Clinical Trials in Organ Transplantation; Cooperative Clinical Trials in Pediatric...CompletedKidney Transplant | Kidney Transplant Recipient | Graft Function/Survival | de Novo HLA Antibodies DevelopmentUnited States
-
Klemens BuddeCharite University, Berlin, Germany; Dr. med. univ. L. J. Lehner; ERA-EDTA; DESCARTES... and other collaboratorsNot yet recruitingInfections | Quality of Life | Death | Cardiovascular Risk Factors | Graft Failure | Bone Disease | Post Transplant Diabetes Mellitus | Acute Rejection of Renal Transplant | HLA Antibody Production | Non-HLA Antibody Production
-
Bursa Postgraduate HospitalCompletedContrast Agents and Oral Factor Xa InhibitorTurkey
-
Duke UniversityNational Institute of Allergy and Infectious Diseases (NIAID); University of... and other collaboratorsRecruitingCommon Variable Immunodeficiency | X-linked Agammaglobulinemia | Primary Immune Deficiency | Primary Antibody Deficiencies | CVID | XLA | Secondary HypogammaglobulinemiaUnited States
-
IVI MadridCompletedMaternal-Fetal KIR-HLA-C Compatibility
-
SymateseEVAMEDRecruitingFacial Lipoatrophy (FLA)France
-
Albert Einstein College of MedicineNational Cancer Institute (NCI)TerminatedMetastatic Malignant Neoplasm in the Brain | Metastatic Malignant Neoplasm | HLA-A2 Positive Cells PresentUnited States
-
AstraZenecaRecruitingLife Threatening Bleeding | Factor Xa InhibitorJapan
-
Jonsson Comprehensive Cancer CenterCalifornia Institute for Regenerative Medicine (CIRM)TerminatedSarcoma | Unresectable Malignant Neoplasm | Locally Advanced Malignant Neoplasm | HLA-A*0201 Positive Cells Present | NY-ESO-1 PositiveUnited States
-
Assistance Publique - Hôpitaux de ParisNot yet recruitingMuscle Weakness | XLH
-
Hadassah Medical OrganizationUnknownMetastatic Disease | High Risk HLA-A2+ Melanoma
-
Sidney Kimmel Comprehensive Cancer Center at Johns...CompletedMyeloablative Conditioning | HLA-mismatched Bone Marrow Transplantation | Graft Survival | Transplantation, Bone MarrowCanada, United States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedRecurrent Ovarian Carcinoma | HLA-A*0201 Positive Cells Present | COL6A3 Positive | PRAME PositiveUnited States
-
Mitsubishi Tanabe Pharma America Inc.Active, not recruitingEPP | XLPUnited States, Germany, Japan, Spain, Italy, Sweden, Australia, Canada, Norway, United Kingdom
-
Mitsubishi Tanabe Pharma America Inc.CompletedEPP | XLPSpain, United States, Germany, Norway, Italy, Australia, Canada, Japan, Sweden, United Kingdom
-
The Hospital for Sick ChildrenCompletedX-linked Lymphoproliferative Syndrome Type 2 (XLP-2)Canada
-
Southeast University, ChinaUnknownCritically Ill | Anti-XaChina
-
University Hospital, GrenobleTerminatedKidney Transplantation | End-stage Renal Disease | Hla-incompatible Kidney Transplant CandidatesFrance
-
Charite University, Berlin, GermanyUniversity of LeipzigUnknownAcute Myeloid Leukemias | Advanced Hematological Malignancies | Indication for Allogeneic Stem Cell Transplantation | no HLA-identical Donor AvailableGermany
-
Assistance Publique - Hôpitaux de ParisCompletedHereditary Diseases | Relapse | Acquired Aplastic Anemia | Absence of an HLA Identical DonorFrance
-
Roswell Park Cancer InstituteNational Cancer Institute (NCI)RecruitingRefractory Melanoma | HLA-A2 Positive Cells PresentUnited States
-
Icahn School of Medicine at Mount SinaiNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)CompletedErythropoietic Protoporphyria | EPP | X-linked Protoporphyria | XLPUnited States
-
Mitsubishi Tanabe Pharma America Inc.RecruitingErythropoietic Protoporphyria (EPP) | X-Linked Protoporphyria (XLP)United States, Spain, France, United Kingdom, Japan, Italy, Australia, Bulgaria, Czechia, Netherlands, Poland
-
Yale UniversityNational Center for Advancing Translational Sciences (NCATS)SuspendedRickets | Hypophosphatemia | Hypercalciuria | XLH | HHRHUnited States
-
Medical University of GdanskBaxter Healthcare CorporationUnknownAssessment of Activity of Anti-Xa Factor in Patients Treated With Continuous Veno-venous Hemodiafiltration Receiving Anticoagulant ProphylaxisPoland
-
Mohamed Sayed Mohamed AbbasCompletedAnti-Xa Assay in Pulmonary Embolism
-
Weill Medical College of Cornell UniversityUniversity of California, Los Angeles; University of Wisconsin, MilwaukeeCompletedTourette's Syndrome | Tourette's Disorder | Tourette Disorder | Gilles de la Tourette Syndrome | Tourette's Disease | Tourette Disease | Tic Disorder, Combined Vocal and Multiple Motor | Multiple Motor and Vocal Tic Disorder, Combined | Gilles de La Tourette's Disease | Gilles De La Tourette's Syndrome | Combined... and other conditions
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)TerminatedAcute Myeloid Leukemia | EBV-Positive Neoplastic Cells Present | HLA-A*0201 Positive Cells Present | Blasts Under 5 Percent of Bone Marrow Nucleated Cells | Elevated WT1United States
-
Icahn School of Medicine at Mount SinaiNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Rare... and other collaboratorsCompletedErythropoietic Protoporphyria | EPP | XLP | X-Linked Protoporphyria | XLPP | X-Linked Dominant Erythropoietic Protoporphyria | XLEPP | XLDPUnited States
-
Alnylam PharmaceuticalsCompletedAcute Hepatic Porphyria | Acute Intermittent Porphyria | Porphyria, Acute Intermittent | Acute Porphyria | Hereditary Coproporphyria (HCP) | Variegate Porphyria (VP) | ALA Dehydratase Deficient Porphyria (ADP)United States, Spain, United Kingdom, Korea, Republic of, Australia, Bulgaria, Canada, Denmark, Finland, France, Germany, Italy, Japan, Mexico, Netherlands, Poland, Sweden, Taiwan
-
Assistance Publique - Hôpitaux de ParisRecruitingPediatric Patients | Any Type of Severe Combined Immunodeficiency (SCID) | Partial HLA Incompatible Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)France
-
M.D. Anderson Cancer CenterCompletedRecurrent Synovial Sarcoma | HLA-A*0201 Positive Cells Present | NY-ESO-1 Positive Tumor Cells Present | Recurrent Myxoid LiposarcomaUnited States
-
University Health Network, TorontoTakara Bio Inc.Active, not recruitingMelanoma | Esophageal Cancer | Ovarian Cancer | Lung Cancer | Bladder Cancer | Liver Cancer | Synovial Sarcoma | NY-ESO-1 Expressing Solid Tumors in HLA-A2 Positive PatientsCanada
-
Jonsson Comprehensive Cancer CenterNovartis PharmaceuticalsWithdrawnRefractory Plasma Cell Myeloma | Recurrent Plasma Cell Myeloma | HLA-A*0201 Positive Cells Present | NY-ESO-1 Positive Tumor Cells PresentUnited States
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)TerminatedRecurrent Adult Acute Myeloid Leukemia | Secondary Acute Myeloid Leukemia | Recurrent Acute Myeloid Leukemia | Recurrent Childhood Acute Myeloid Leukemia | Therapy-Related Acute Myeloid Leukemia | Donor | Hematopoietic Cell Transplant Recipient | HLA-A*0201 Positive Cells PresentUnited States
-
University Health Network, TorontoAstraZeneca; NeoGenomics LaboratoriesRecruitingLocoregionally Advanced Head and Neck Squamous Cell Carcinoma (LA-HNSCC)Canada